Genetic and Chemical Targeting of Epithelial-Restricted With Serine Box Reduces EGF Receptor and Potentiates the Efficacy of Afatinib
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-12-1110
Full Text
Open PDFAbstract
Available in full text
Date
May 30, 2013
Authors
Publisher
American Association for Cancer Research (AACR)